FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W30801341> ?p ?o ?g. }

• W30801341 abstract "Abstract Low cholesterol levels can be detected in solid tumors and hematological malignancies such as muliple myeloma. Moreover chloesterol levels reduced in some experimental studies of patients with chronic lymphocytic leukemia (CLL). In this retrospective multicenter study, lipid levels were retrospectively evaluated in 420 (264 male and 256 female with mean age 64 ± 11 years) patients with newly diagnosed CLL, according to the International CLL study group. 71 (28 male and 43 female with mean age 55 ± 9 years) healthy subjects as control group were included to this study. Lipid parameters such as total cholesterol (TC), high density lipoprotein-cholesterol (HDL-C), very low-density lipoprotein-cholesterol (VLDL-C), and triglyceride levels were measured with enzymatic/ calorimetric method and Architect C800 instrument. Low-density lipoprotein-cholesterol (LDL-C) levels were calculated according to Friedwald formula. Lipid parameters between two groups were compared with Mann-Whitney U test. A value of p< 0.05 was accepted as statistically significant. According to Binet classification, 60% of patients were in stage A, while 25% of them were in stage C. In CLL patients, the levels of TC, HDL-C, and LDL-C were lower than those of control group (p=0.001). There was no significantly difference for triglyceride and VLDL-C levels between two groups (p>0.05) (Table-1). The levels of TC, LDL-C, and HDL-C in the patients with stage C were lower than those of both stage A and stage B (Table-2). Low cholesterol levels in patients with CLL may occur due to increased use of cholesterol by lymphocytes.Table-1Lipid parameters in control group and CLL patientsCLL (N:420)Control (N:71)P valueTC (mg/dl)175±41217±36<0.001HDL-C (mg/dl)37±1153±14<0.001LDL-C (mg/dl)108±30131±29<0.001Triglyceride (mg/dl)140±71147±68>0.05VLDL-C (mg/dl)31±1731±17>0.05Table 2Lipid parameters in the patients according to Binet classificationStage A (n:255)Stage B(n:61)Stage C(n:104)P valueTC(mg/dl)183±38179±43156±40<0.001HDL-C(mg/dl)40±1237±1232±12<0.001LDL-C (mg/dl)112±28110±3398±30<0.001Triglyceride (mg/dl)141±76136±53141±68>0.05VLDL-C(mg/dl)30±1535±3331±13>0.05 Disclosures: Sonmez: Novartis Pharmaceuticals Corporation, Turkey: Membership on an entity’s Board of Directors or advisory committees." @default.
• W30801341 created "2016-06-24" @default.
• W30801341 creator A5003718731 @default.
• W30801341 creator A5005530639 @default.
• W30801341 creator A5013426898 @default.
• W30801341 creator A5018463325 @default.
• W30801341 creator A5032054319 @default.
• W30801341 creator A5037716962 @default.
• W30801341 creator A5041890094 @default.
• W30801341 creator A5043616595 @default.
• W30801341 creator A5044684356 @default.
• W30801341 creator A5044930804 @default.
• W30801341 creator A5064328293 @default.
• W30801341 creator A5067702018 @default.
• W30801341 creator A5069346309 @default.
• W30801341 creator A5075639078 @default.
• W30801341 creator A5081933824 @default.
• W30801341 creator A5082089864 @default.
• W30801341 creator A5084433041 @default.
• W30801341 date "2013-11-15" @default.
• W30801341 modified "2023-09-27" @default.
• W30801341 title "Cholesterol Levels In Patients With Newly Diagnosed Chronic Lymphocytic Leukemia: A retrospective Multicenter Study" @default.
• W30801341 doi "https://doi.org/10.1182/blood.v122.21.5292.5292" @default.
• W30801341 hasPublicationYear "2013" @default.
• W30801341 type Work @default.
• W30801341 sameAs 30801341 @default.
• W30801341 citedByCount "0" @default.
• W30801341 crossrefType "journal-article" @default.
• W30801341 hasAuthorship W30801341A5003718731 @default.
• W30801341 hasAuthorship W30801341A5005530639 @default.
• W30801341 hasAuthorship W30801341A5013426898 @default.
• W30801341 hasAuthorship W30801341A5018463325 @default.
• W30801341 hasAuthorship W30801341A5032054319 @default.
• W30801341 hasAuthorship W30801341A5037716962 @default.
• W30801341 hasAuthorship W30801341A5041890094 @default.
• W30801341 hasAuthorship W30801341A5043616595 @default.
• W30801341 hasAuthorship W30801341A5044684356 @default.
• W30801341 hasAuthorship W30801341A5044930804 @default.
• W30801341 hasAuthorship W30801341A5064328293 @default.
• W30801341 hasAuthorship W30801341A5067702018 @default.
• W30801341 hasAuthorship W30801341A5069346309 @default.
• W30801341 hasAuthorship W30801341A5075639078 @default.
• W30801341 hasAuthorship W30801341A5081933824 @default.
• W30801341 hasAuthorship W30801341A5082089864 @default.
• W30801341 hasAuthorship W30801341A5084433041 @default.
• W30801341 hasConcept C126322002 @default.
• W30801341 hasConcept C134018914 @default.
• W30801341 hasConcept C167135981 @default.
• W30801341 hasConcept C2777938653 @default.
• W30801341 hasConcept C2778163477 @default.
• W30801341 hasConcept C2778461978 @default.
• W30801341 hasConcept C2778913445 @default.
• W30801341 hasConcept C2780072125 @default.
• W30801341 hasConcept C71924100 @default.
• W30801341 hasConcept C8243546 @default.
• W30801341 hasConcept C90924648 @default.
• W30801341 hasConceptScore W30801341C126322002 @default.
• W30801341 hasConceptScore W30801341C134018914 @default.
• W30801341 hasConceptScore W30801341C167135981 @default.
• W30801341 hasConceptScore W30801341C2777938653 @default.
• W30801341 hasConceptScore W30801341C2778163477 @default.
• W30801341 hasConceptScore W30801341C2778461978 @default.
• W30801341 hasConceptScore W30801341C2778913445 @default.
• W30801341 hasConceptScore W30801341C2780072125 @default.
• W30801341 hasConceptScore W30801341C71924100 @default.
• W30801341 hasConceptScore W30801341C8243546 @default.
• W30801341 hasConceptScore W30801341C90924648 @default.
• W30801341 hasLocation W308013411 @default.
• W30801341 hasOpenAccess W30801341 @default.
• W30801341 hasPrimaryLocation W308013411 @default.
• W30801341 hasRelatedWork W1985994537 @default.
• W30801341 hasRelatedWork W2028615279 @default.
• W30801341 hasRelatedWork W2159724989 @default.
• W30801341 hasRelatedWork W2183729551 @default.
• W30801341 hasRelatedWork W2186909113 @default.
• W30801341 hasRelatedWork W2287642836 @default.
• W30801341 hasRelatedWork W2413815720 @default.
• W30801341 hasRelatedWork W2418843090 @default.
• W30801341 hasRelatedWork W2425065192 @default.
• W30801341 hasRelatedWork W2535500964 @default.
• W30801341 hasRelatedWork W2553760059 @default.
• W30801341 hasRelatedWork W2565259875 @default.
• W30801341 hasRelatedWork W2572755757 @default.
• W30801341 hasRelatedWork W3029632738 @default.
• W30801341 hasRelatedWork W3115348052 @default.
• W30801341 hasRelatedWork W3136275024 @default.
• W30801341 hasRelatedWork W3175711304 @default.
• W30801341 hasRelatedWork W3197528139 @default.
• W30801341 hasRelatedWork W38404531 @default.
• W30801341 hasRelatedWork W988957 @default.
• W30801341 isParatext "false" @default.
• W30801341 isRetracted "false" @default.
• W30801341 magId "30801341" @default.
• W30801341 workType "article" @default.